BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 22043906)

  • 21. The propagation of prion-like protein inclusions in neurodegenerative diseases.
    Goedert M; Clavaguera F; Tolnay M
    Trends Neurosci; 2010 Jul; 33(7):317-25. PubMed ID: 20493564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of astrocytes in prion-like mechanisms of neurodegeneration.
    Smethurst P; Franklin H; Clarke BE; Sidle K; Patani R
    Brain; 2022 Mar; 145(1):17-26. PubMed ID: 35265969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propagation of the prion phenomenon: beyond the seeding principle.
    Münch C; Bertolotti A
    J Mol Biol; 2012 Aug; 421(4-5):491-8. PubMed ID: 22245492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
    Gaggelli E; Kozlowski H; Valensin D; Valensin G
    Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
    [No Abstract]   [Full Text] [Related]  

  • 25. Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases.
    Walker LC
    Annu Rev Genet; 2016 Nov; 50():329-346. PubMed ID: 27893962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurodegenerative conformational disease and its molecular bases].
    Li WW; Cai DF; Ren HM
    Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and function of the molecular chaperone Hsp104 from yeast.
    Grimminger-Marquardt V; Lashuel HA
    Biopolymers; 2010 Mar; 93(3):252-76. PubMed ID: 19768774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein aggregation and prionopathies.
    Renner M; Melki R
    Pathol Biol (Paris); 2014 Jun; 62(3):162-8. PubMed ID: 24698014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion, prionoids and infectious amyloid.
    Liberski PP
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S80-4. PubMed ID: 24262195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prion and prion-like diseases in animals.
    Aguilar-Calvo P; García C; Espinosa JC; Andreoletti O; Torres JM
    Virus Res; 2015 Sep; 207():82-93. PubMed ID: 25444937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-free formation of misfolded prion protein with authentic prion infectivity.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15818-23. PubMed ID: 17030802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prions: generation and spread versus neurotoxicity.
    Halliday M; Radford H; Mallucci GR
    J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The controversial protein-only hypothesis of prion propagation.
    Soto C; Castilla J
    Nat Med; 2004 Jul; 10 Suppl():S63-7. PubMed ID: 15272271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease.
    Morris RJ; Parkyn CJ; Jen A
    FEBS Lett; 2006 Oct; 580(23):5565-71. PubMed ID: 16884720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Misfolding of the prion protein: linking biophysical and biological approaches.
    Noinville S; Chich JF; Rezaei H
    Vet Res; 2008; 39(4):48. PubMed ID: 18533092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease-associated protein seeding suggests a dissociation between misfolded protein accumulation and neurodegeneration in prion disease.
    Alibhai J; Diack A; Manson J
    Prion; 2017 Nov; 11(6):381-387. PubMed ID: 29023184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
    Tenreiro S; Munder MC; Alberti S; Outeiro TF
    J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.